At the 79th World Health Assembly (WHA79) in Geneva (May 2026), WHO Member States adopted the updated Global Action Plan on Antimicrobial Resistance (GAP-AMR) 2026–2036, providing a 10-year roadmap to combat antimicrobial resistance through a One Health approach that integrates human, animal, plant and environmental health.
Key Recommendations and Strategic Priorities of the WHO AMR Action Plan (2026–2036)
1. Put Prevention First
The plan emphasizes preventing infections before they occur, thereby reducing the need for antimicrobials. Recommended actions include:
- Strengthening infection prevention and control (IPC) in healthcare settings.
- Expanding access to clean water, sanitation and hygiene (WASH).
- Increasing vaccination coverage in humans and animals.
- Improving biosecurity in agriculture and livestock production.
- Reducing environmental contamination that promotes resistant organisms.
2. Ensure Responsible and Sustainable Use of Antimicrobials
WHO calls for:
- Better antimicrobial stewardship programmes in hospitals and communities.
- Reducing unnecessary antibiotic prescribing.
- Restricting inappropriate antimicrobial use in livestock, aquaculture and crop production.
- Promoting access to quality-assured medicines while preventing misuse and overuse.
3. Strengthen Surveillance and Laboratory Capacity
Countries are encouraged to:
- Expand national AMR surveillance systems.
- Improve laboratory infrastructure and diagnostic capacity.
- Participate in WHO’s Global Antimicrobial Resistance and Use Surveillance System (GLASS).
- Collect data on antimicrobial consumption and resistance patterns across sectors.
4. Adopt a Full One Health Approach
The updated plan recognizes that AMR emerges and spreads across humans, animals, food systems and the environment. Governments are encouraged to:
- Establish cross-sector coordination mechanisms.
- Integrate AMR policies across health, agriculture, veterinary and environmental ministries.
- Address antimicrobial residues and resistant organisms in wastewater, soil and food production systems.
5. Improve Access to Effective Medicines and Diagnostics
WHO recommends:
- Expanding equitable access to essential antimicrobials, diagnostics and vaccines.
- Reducing shortages of critical antibiotics.
- Ensuring that low- and middle-income countries can access effective treatments without encouraging inappropriate use.
6. Accelerate Research, Innovation and Development
The plan highlights the need for:
- New antibiotics and alternative therapies.
- Rapid diagnostic technologies.
- Vaccines that can reduce antibiotic demand.
- Innovative financing mechanisms and incentives to support antimicrobial R&D.
7. Secure Sustainable Financing
Countries are urged to:
- Allocate dedicated domestic funding for AMR programmes.
- Integrate AMR activities into broader health-system strengthening efforts.
- Mobilize international financing and development assistance where needed.
8. Strengthen Governance, Accountability and Monitoring
The action plan calls for:
- Updated and costed national AMR action plans.
- Regular monitoring and reporting of progress.
- Clear accountability mechanisms at national and global levels.
- Measurement of outcomes against agreed global targets.
Global Targets Highlighted by WHO
The updated GAP-AMR is aligned with commitments made at the 2024 UN High-Level Meeting on AMR. Among its objectives are:
- Achieving a 10% reduction in bacterial AMR-associated deaths in humans by 2030.
- Reducing antimicrobial use in agrifood systems.
- Minimizing environmental pollution from antimicrobial residues and resistant microbes.
Relevance for India
Many of these priorities align closely with India’s National Action Plan on AMR (AMR 2.0, 2025–2035), particularly:
- Strengthening the One Health framework.
- Expanding AMR surveillance networks.
- Improving infection prevention and WASH infrastructure.
- Enhancing antimicrobial stewardship in hospitals.
- Regulating antimicrobial use in livestock and agriculture.
- Increasing public awareness and professional training. These areas are likely to receive greater policy attention as countries implement the new WHO roadmap.
In summary: The WHO AMR Action Plan 2026–2036 shifts the global response from merely controlling antibiotic misuse to a broader strategy focused on prevention, surveillance, One Health coordination, equitable access, innovation, sustainable financing and accountability, with the overarching goal of preserving the effectiveness of antimicrobials for future generations.

